These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7433767)

  • 1. The importance of catecholamine uptake inhibition in the reversal of guanethidine blockade of adrenergic neurons.
    Lee CH; Strosberg AM; Warren LA
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):3-14. PubMed ID: 7433767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial reversal of guanethidine-induced adrenergic neuron blockade by acetaldehyde.
    Lai FM; Hudgins PM
    Toxicol Appl Pharmacol; 1975 May; 32(2):377-84. PubMed ID: 1154401
    [No Abstract]   [Full Text] [Related]  

  • 3. The adrenergic neuron blocking activity of propranolol and alprenolol.
    Del Río J; López De Ceballos M
    Arch Farmacol Toxicol; 1975 Aug; 1(2):125-36. PubMed ID: 1230027
    [No Abstract]   [Full Text] [Related]  

  • 4. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.
    Mitchell JR; Cavanaugh JH; Arias L; Oates JA
    J Clin Invest; 1970 Aug; 49(8):1596-604. PubMed ID: 5431666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the action of guanethidine on adrenergic neurones.
    Gulati OD; Jaykar S
    Br J Pharmacol; 1971 Jul; 42(3):352-63. PubMed ID: 5560897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Mechanism of antidepressant efficacy of monoamine oxidase inhibitors: inhibition of monoamine oxidase or of catecholamine reuptake.
    Snyder SH
    Psychopharmacol Bull; 1974 Oct; 10(4):16. PubMed ID: 4431859
    [No Abstract]   [Full Text] [Related]  

  • 7. The relation between the adrenergic neurone-blocking and noradrenaline-depleting actions of some guanidine derivatives.
    Abbs ET; Dodd MG
    Br J Pharmacol; 1974 Jun; 51(2):237-47. PubMed ID: 4451743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
    Lorez HP
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of the antagonism between guanethidine and dexamphetamine.
    Gerkens JF; McCulloch MW
    Br J Pharmacol; 1969 Mar; 35(3):563-72. PubMed ID: 5809745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between desmethylimipramine and guanethidine on the rabbit ileum. The importance of the noradrenaline uptake process in the reversal of guanethidine-induced adrenergic neurone blockade.
    Atkinson R; Watkinson B; Weetman DF
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):385-91. PubMed ID: 5054741
    [No Abstract]   [Full Text] [Related]  

  • 11. Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs.
    Mitchell JR; Oates JA
    J Pharmacol Exp Ther; 1970 Mar; 172(1):100-7. PubMed ID: 5416937
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of neuronal activity levels on the cytotoxic effects of guanethidine.
    Evans BK
    J Pharmacol Exp Ther; 1979 May; 209(2):205-14. PubMed ID: 438995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of guanethidine blockade of sympathetic nerve terminals by tetraethylammonium and 4-aminopyridine.
    Kirpekar M; Kirpekar SM; Prat JC
    Br J Pharmacol; 1978 Jan; 62(1):75-8. PubMed ID: 620099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron.
    Raisfeld IH
    Am Heart J; 1972 Jan; 83(1):129-33. PubMed ID: 4551683
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prolonged treatment with adrenergic neuron blocking drugs on sympathoadrenal reactivity in rats.
    Grobecker H; Roizen MF; Jacobowitz DM; Kopin IJ
    Eur J Pharmacol; 1977 Nov; 46(2):125-33. PubMed ID: 590325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic and thermodynamic considerations regarding the inhibition by tricyclic antidepressants of the uptake of tritiated norepinephrine by the adrenergic nerves in rabbit aortic strips.
    Maxwell RA; Eckhardt SB; Hite G
    J Pharmacol Exp Ther; 1970 Jan; 171(1):62-9. PubMed ID: 5410938
    [No Abstract]   [Full Text] [Related]  

  • 17. Some studies on the mechanism by which d-amphetamine antagonizes guanethidine induced adrenergic neurone blockade.
    Obianwu HO
    Acta Physiol Scand; 1969; 75(1):102-10. PubMed ID: 5785131
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 19. Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent.
    Chen MJ; Russo-Neustadt AA
    Growth Factors; 2007 Apr; 25(2):118-31. PubMed ID: 17852404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.